Caloric restriction: Implications for human cardiometabolic health

Journal of Cardiopulmonary Rehabilitation and Prevention

Volumn 33, Issue 4, 2013, Pages 201-208

  Bales, Connie W ^a,b   Kraus, William E ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DURHAM VA MEDICAL CENTER   (United States)

Author keywords

calorie restriction; cardiovascular disease; health span; human cardiometabolic health; longevity; maximal life span; primary and secondary aging

Indexed keywords

ADIPONECTIN; ADVANCED GLYCATION END PRODUCT; C REACTIVE PROTEIN; CHOLESTEROL; ENDOTOXIN; GLYCOSYLATED PROTEIN; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 6; LEPTIN; LIPID; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OXYGEN; PENTOSIDINE; TRACE ELEMENT; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

AGING; APOPTOSIS; ATHEROSCLEROTIC CARDIOVASCULAR DISEASE; BODY TEMPERATURE; CALORIC INTAKE; CALORIC RESTRICTION; CALORIE; CARDIOMETABOLIC RISK; CARDIOVASCULAR SYSTEM; CHOLESTEROL BLOOD LEVEL; CHRONIC INFLAMMATION; COGNITIVE DEFECT; COMORBIDITY; CYTOKINE PRODUCTION; DIASTOLIC BLOOD PRESSURE; DYSLIPIDEMIA; FITNESS; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE TRANSPORT; HEALTH; HEART FAILURE; HUMAN; INFLAMMATION; INSULIN SENSITIVITY; ISCHEMIC HEART DISEASE; LIFESTYLE; LONGEVITY; METABOLIC SYNDROME X; NONHUMAN; OBESITY; PRIORITY JOURNAL; REVIEW; SURVIVAL; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; WEIGHT REDUCTION;

AGING; CALORIC RESTRICTION; CARDIOVASCULAR DISEASES; ENERGY INTAKE; HUMANS; LIFE STYLE; OBESITY;

EID: 84880324400     PISSN: 19327501     EISSN: 1932751X     Source Type: Journal    
DOI: 10.1097/HCR.0b013e318295019e     Document Type: Review

References (70)

1. McCay CM, Crowell MF, Maynard LA. The effect of retarded growth upon the length of the life span and upon the ultimate body size. J Nutr. 1935;10:63-70.
2. Rebrin I, Forster MJ, Sohal RS. Association between life-span extension by caloric restriction and thiol redox state in two different strains of mice. Free Radic Biol Med. 2011;51:225-233.
3. Rochon J, Bales CW, Ravussin E, et al. Design and conduct of the CALERIE study:comprehensive assessment of the long-term effects of reducing intake of energy. J Gerontol A Biol Sci Med Sci. 2011;66:97-108.
4. Mattison JA, Roth GS, Lane MA, Ingram DK. Dietary restriction in aging nonhuman primates. Interdiscip Top Gerontol. 2007;35:137-158.
5. Weindruch R. Caloric restriction and aging. Sci Am. 1996;274:46-52.
6. Weindruch R, Walford RL, Fligiel S, Guthrie D. The retardation of aging in mice by dietary restriction:longevity, cancer, immunity and lifetime energy intake. J Nutr. 1986;116:641-654.
7. Fontana L. Calorie restriction and cardiometabolic health. Eur J Cardiovasc Prev Rehabil. 2008; 15: 3-9.
8. Masoro EJ, Iwasaki K, Gleiser CA, McMahan CA, Seo EJ, Yu BP. Dietary modulation of the progression of nephropathy in aging rats:an evaluation of the importance of protein. Am J Clinical Nutr. 1989;49:1217-1227.
9. Masoro EJ. Overview of caloric restriction and ageing. Mech Age Dev. 2005;126:913-922.
10. Dolinsky VW, Dyck JR. Calorie restriction and resveratrol in cardiovascular health and disease. Biochim Biophys Acta. 2011;1812:1477-1489.
11. Cruzen C, Colman RJ. Effects of caloric restriction on cardiovascular aging in non-human primates and humans. Clin Geriatr Med. 2009;25:733-743, ix-x.
12. Colman RJ, Anderson RM, Johnson SC, et al. Caloric restriction delays disease onset and mortality in rhesus monkeys. Science. 2009;325 (5937):201-204.
13. Weindruch R, Walford RL. Dietary restriction in mice beginning at 1 year of age:effect on life-span and spontaneous cancer incidence. Science. 1982;215:1415-1418.
14. Yu BP, Masoro EJ, McMahan CA. Nutritional influences on aging of Fischer 344 rats I. Physical, metabolic, and longevity characteristics. J Gerontol. 1985;40:657-670.
15. Masoro EJ, Yu BP, Bertrand HA. Action of food restriction in delaying the aging process. Proc Natl Acad Sci USA. 1982;79:4239-4241.
16. Harrison DE, Archer JR, Astole CM. Effects of food on aging:separation of food intake and adiposity. Proc Natl Acad Sci USA. 1984;81:1835-1838.
17. Masoro EJ. Caloric restriction-induced life extension of rats and mice:A critique of proposed mechanisms. Biochim Biophys Acta. 2009;1790:1040-1048.
18. Turturro A, Hass B, Hart RW. Hormesis\implications for risk assessment caloric intake (body weight) as an exemplar. Hum Exp Toxicol. 1998;17:454-459.
19. Masoro EJ. Hormesis and the antiaging action of dietary restriction. Exp Gerontol. 1998;31:61-66.
20. Ingram DK, Roth GS, Lane MA, et al. The potential for dietary restriction to increase longevity in humans:extrapolation from monkey studies. Biogerontology. 2006;7:143-148.
21. Barger JL, Walford RL, Weindruch R. The retardation of aging by caloric restriction:its significance in the transgenic era. Exp Gerontol. 2003;38:1343-1351.
22. Fontana L, Meyer TE, Klein S, Holloszy JO. Long-term calorie restriction is highly effective in reducing the risk for atherosclerosis in humans. Proc Natl Acad Sci USA. 2004; 101: 6659-6663.
23. Fontana L. The scientific basis of caloric restriction leading to longer life. Curr Opin Gastroenterol. 2009; 25: 144-150.
24. Walford RL, Mock D, Verdery R, MacCallum T. Calorie restriction in biosphere 2:alterations in physiologic, hematologic, hormonal, and biochemical parameters in humans restricted for a 2-year period. J Gerontol A Biol Sci Med Sci. 2002;57:B211-B224.
25. Meyer TE, Kovacs SJ, Ehsani AA, Klein S, Holloszy JO, Fontana L. Long-term caloric restriction ameliorates the decline in diastolic function in humans. J Am Coll Cardiol. 2006;47:398-402.
26. Spindler SR. Caloric restriction:from soup to nuts. Ageing Res Rev. 2010;9:324-353.
27. Gu D, He J, Duan X, et al. Body weight and mortality among men and women in China. JAMA. 2006;295:776-783.
28. Zainal TA, Oberley TD, Allison DB, Szweda LI, Weindruch R. Caloric restriction of rhesus monkeys lowers oxidative damage in skeletal muscle. FASEB J. 2000;14:1825-1836.
29. Goldstein JL, Hobbs HH, Brown MS. Familial hypercholester-olemia. In:Scriver CR, Beaudet AL, Sly WS, et al, eds. The Metabolic &Molecular Bases of Inherited Disease. New York, NY:McGraw-Hill;2001:2863-2913.
30. Reardon CA, Getz GS. Mouse models of atherosclerosis. Curr Opin Lipidol. 2001;12:167-173.
31. Gotto AMJ, Grundy SM. Lowering LDL cholesterol:questions from recent meta-analyses and subset analyses of clinical trial DataIssues from the Interdisciplinary Council on Reducing the Risk for Coronary Heart Disease, ninth council meeting. Circulation. 1999;99:E1-E7.
32. Katzel LI, Bleecker ER, Colman EG, Rogus EM, Sorkin JD, Goldberg AP. Effects of weight loss vs aerobic exercise training on risk factors for coronary disease in healthy, obese, middle-aged and older men. A randomized controlled trial. JAMA. 1995;274:1915-1921.
33. Ross R, Dagnone D, Jones PJ, et al. Reduction in obesity and related comorbid conditions after diet-induced weight loss or exercise-induced weight loss in men. A randomized, controlled trial. Ann Intern Med. 2000;133:92-103.
34. Verdery RB, Walford RL. Changes in plasma lipids and lipopro-teins in humans during a 2-year period of dietary restriction in Biosphere 2. Arch Intern Med. 1998;158:900-906.
35. Walford RL, Harris SB, Gunion MW. The calorically restricted low-fat nutrient-dense diet in Biosphere 2 significantly lowers blood glucose, total leukocyte count, cholesterol, and blood pressure in humans. Proc Nat Acad Sci USA. 1992;89:11533-11537.
36. Burt VL, Whelton P, Roccella EJ, et al. Prevalence of hypertension in the US adult population:results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension. 1995;25:305-313.
37. Lane MA, Ingram DK, Roth GS. Calorie restriction in nonhuman primates:effects on diabetes and cardiovascular disease risk. Toxicol Sci. 1999;52 (2) (suppl):41-48.
38. Cohen HJ, Pieper CF, Harris T, Rao KM, Currie MS. The association of plasma IL-6 levels with functional disability in community-dwelling elderly. J Gerontol A Biol Sci Med Sci. 1997;52:M201-M208.
39. Ershler WB, Sun WH, Binkley N, et al. Interleukin-6 and aging:blood levels and mononuclear cell production increase with advancing age and in vitro production is modifiable by dietary restriction. Lymphokine Cytokine Res. 1993;12:225-230.
40. Basta G, Schmidt AM, De Caterina R. Advanced glycation end products and vascular inflammation:implications for accelerated atherosclerosis in diabetes. Cardiovasc Res. 2004;63:582-592.
41. Cefalu WT, Wagner JD, Bell-Farrow AD, et al. Influence of caloric restriction on the development of atherosclerosis in nonhuman primates:progress to date. Toxicol Sci. 1999;52 (2) (suppl):49-55.
42. Novelli M, Masiello P, Bombara M, Bergamini E. Protein glycation in the aging male Sprague-Dawley rat:effects of antiaging diet restrictions. J Gerontol A Biol Sci Med Sci. 1998;53:B94-B101.
43. Assayag P, Charlemagne D, de Leiris J, et al. Senescent heart compared with pressure overload-induced hypertrophy. Hypertension. 1997;29:15-21.
44. Benetos A, Laurent S, Hoeks AP, Boutouyrie PH, Safar ME. Arterial alterations with aging and high blood pressure. A non-invasive study of carotid and femoral arteries. Arterioscler Thromb. 1993;13:90-97.
45. Gaballa MA, Jacob CT, Raya TE, Liu J, Simon B, Goldman S. Large artery remodeling during aging:biaxial passive and active stiffness. Hypertension. 1998;32:437-443.
46. Michel JB, Salzmann JL, Cerol ML, et al. Myocardial effect of converting enzyme inhibition in hypertensive and normoten-sive rats. Am J Med. 1988;84:12-21.
47. Basso N, Paglia N, Stella I, et al. Protective effect of the inhibition of the renin-angiotensin system on aging. Regul Pept. 2005;128:247-252.
48. Brilla CG, Pick R, Tan L, Janicki JS, Weber KT. Remodeling of the rat right and left ventricles in experimental hypertension. Circ Res. 1990;67:1355-1364.
49. Brilla CG, Weber KT. Reactive and reparative myocardial fibro-sis in arterial hypertension in the rat. Cardiovasc Res. 1992;26:671-677.
50. Loffreda S, Yang SQ, Lin HZ, et al. Leptin regulates proinflam-matory immune responses. FASEB J. 1998;12:57-65.
51. Sader S, Nian M, Liu P. Leptin:A novel link between obesity, diabetes, cardiovascular risk, and ventricular hypertrophy. Circulation. 2003;108:644-646.
52. Lavie CJ, De Schutter A, Patel DA, Romero-Corral A, Artham SM, Milani RV. Body composition and survival in stable coronary heart disease:impact of lean mass index and body fat in the "obesity paradox. "J Am Coll Cardiol. 2012;60:1374-1380.
53. Lavie CJ, De Schutter A, Patel D, Artham SM, Milani RV. Body composition and coronary heart disease mortality\an obesity or a lean paradox? Mayo Clin Proc. 2011;86:857-864.
54. Morrow LA, Linares OA, Hill TJ, et al. Age differences in the plasma clearance mechanisms for epinephrine and norepi-nephrine in humans. J Clin Endocrinol Metab. 1987;65:508-511.
55. Veith RC, Featherstone JA, Linares OA, Halter JB. Age differences in plasma norepinephrine kinetics in humans. J Gerontol. 1986;413:319-324.
56. Emdin M, Gastaldelli A, Muscelli E, et al. Hyperinsulinemia and autonomic nervous system dysfunction in obesity:effects of weight loss. Circulation. 2001;103:513-519.
57. Shamsuzzaman ASM, Winnicki M, Wolk R, et al. Independent association between plasma leptin and C-reactive protein in healthy humans. Circulation. 2004;109:2181-2185.
58. Singhal A, Farooqi IS, Cole TJ, et al. Influence of leptin on arterial distensibility:A novel link between obesity and cardiovascular disease? Circulation. 2002;106:1919-1924.
59. Yamauchi T, Kamon J, Waki H, et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med. 2001;7:941-946.
60. Berg AH, Combs TP, Du X, Brownlee M, Scherer PE. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med. 2001;7:947-953.
61. Holloszy JO, Smith EK, Vining M, Adams S. Effect of voluntary exercise on longevity of rats. J Appl Physiol. 1985;59:826-831.
62. Lefevre M, Redman LM, Heilbronn LK, et al. Caloric restriction alone and with exercise improves CVD risk in healthy non-obese individuals. Atherosclerosis. 2009;203:206-213.
63. Fontana L, Villareal DT, Weiss EP, et al. Calorie restriction or exercise:effects on coronary heart disease risk factors. A randomized, controlled trial. Am J Physiol Endocrinol Metabol. 2007;293:E197-E202.
64. Racette SB, Weiss EP, Villareal DT, et al. One year of caloric restriction in humans:feasibility and effects on body composition and abdominal adipose tissue. J Gerontol A Biol Sci Med Sci. 2006;61:943-950.
65. Miller SL, Wolfe RR. The danger of weight loss in the elderly. J Nutr Health Aging. 2008;12:487-491.
66. Kalantar-Zadeh K, Streja E, Kovesdy CP, et al. The obesity paradox and mortality associated with surrogates of body size and muscle mass in patients receiving hemodialysis. Mayo Clin Proc. 2010;85:991-1001.
67. Lavie CJ, Milani RV, Ventura HO. Impact of obesity on outcomes in myocardial infarction combating the "obesity paradox. "J Am Coll Cardiol. 2011;58:2651-2653.
68. Partridge L, Piper MD, Mair W. Dietary restriction in Drosophila. Mech Ageing Dev. 2005;126:938-950.
69. Cheney KE, Liu RK, Smith GS, Meredith PJ, Mickey MR, Walford RL. The effect of dietary restriction of varying duration on survival, tumor patterns, immune function, and body temperature in B10C3F1 female mice. J Gerontol. 1983;38:420-430.
70. Sun L, Sadighi Akha AA, Miller RA, Harper JM. Life-span extension in mice by preweaning food restriction and by methionine restriction in middle age. J Gerontol A Biol Sci Med Sci. 2009;64:711-722.